RPS6KB1 and neoplasm: The consistent negative association of the core components of mTORC1 signaling (S6, p70S6K, and 4E-BP1) with ECM gene expression signatures supports the possibility that chronic mTORC1 inhibition may result in a reorganization of the ECM and that the tumor cells could benefit from novel interactions derived from the ECM.